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i. ordering, receiving and unpacking radioactive materials 
safely and performing the related radiation surveys; 
ii. calibrating dose calibrators and diagnostic instruments and 
performing checks for proper operation ofsurvey meters; 
iii. calculating and safely preparing patient dosages; 
iv. using administrative controls to prevent the misadministra- 
tion of by-product material; 
v. using procedures to contain spilled by-product material 
safely and using proper decontamination procedures; and 
vi. eluting technetium-99m from generator systems, measuring 
and testing the eluate for molybdenum-99 and alumina 
contamination and processing the eluate with reagent kits to 
prepare technetium-99m-labeled radiopharmaceuticals; and 
3. 500 h of supervised clinical experience under the supervision f 
an authorized user that includes 
i. examining patients and reviewing their case histories to 
determine their suitability for radioisotopic diagnosis, limi- 
tations or contraindications; 
ii. selecting the suitable radiopharmaceuticals and calculating 
and measuring the dosages; 
iii. administering dosages topatients and using syringe radiation 
shields; 
iv. collaborating with the authorized user in the interpretation 
of radioisotope t st results; and 
v. patient follow-up; or 
c. Has successfully completed a 6-month training program in 
nuclear medicine that has been approved by the Accreditation 
Council for Graduate Medical Education and that included 
classroom and laboratory training, work experience and super- 
vised clinical experience in all the topics identified in paragraph 
b of this section. 
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Clinical cardiac electrophysiology and cardiac pacing have 
matured significantly and are merging into a common cardiac 
subspecialty discipline. Today, complex cardiac arrhythmias 
are managed by cardiologists and cardiac surgeons with special 
expertise in cardiac electrophysiology, the use of implantable 
pacemakers and cardioverter-defibrillators and the application 
of other interventional techniques and treatments. Nonphar- 
macologic therapy also includes electrophysiologic mapping 
and subsequent catheter or surgical ablation as standard 
treatment for certain tachyarrhythmias. Many new antiarrhyth- 
mic agents with diverse mechanisms of action are often used 
therapeutically alone or in conjunction with implantable mul- 
tiprogrammable arrhythmia control devices (pacemakers and 
implantable cardioverter-defibrillators). 
In 1986, Task Force VI, Training in Cardiac Pacing, and 
Task Force VII, Training in Arrhythmias and Specialized 
Electrophysiologic Studies and Interventions, were published 
separately as a result of the Bethesda Conference 17 on adult 
cardiology training. The present task force combines these two 
closely related disciplines to reflect the current merging of 
science, art and practice of clinical cardiac electrophysiology. 
Genera l  S tandards  and Env i ronment  
General Standards, Facilities and Faculty 
Three organizations, the American College of Cardiology 
(ACC), American Heart Association (AHA) and The North 
American Society of Pacing and Electrophysiology (NASPE), 
have recently addressed training requirements and guidelines 
for pacemaker implantation (1), guidelines for use of implant- 
able cardioverter-defibrillators in cardiovascular p actice (2), 
training requirements for permanent pacemaker selection, 
implantation and follow-up (3) and teaching objectives for 
fellowship programs in clinical electrophysiology (4,5). The 
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training recommendations for these three organizations are 
congruent and address new technologies, faculty and facility 
requirements, aswell as practice standards. 
It is strongly recommended that trainees who desire admis- 
sion to the American Board of Internal Medicine (ABIM) 
examination for certification in Cardiovascular Diseases and 
those who seek admission to the Clinical Cardiac Electrophys- 
iology (CCEP) Examination for certification of added qualifi- 
cations in clinical cardiac etectrophysiology be certain to 
obtain specific requirements from the ABIM. 
The cardiac arrhythmia spects of a cardiology training 
program should meet the published recommendations and 
requirements regarding facilities and faculty (5). Training must 
take place in an Accreditation Council for Graduate Medical 
Education (ACGME) approved training program. The inten- 
sity of training and the required teaching resources may vary 
according to the level of training provided. Facilities hould be 
adequate to ensure a safe, sterile and effective nvironment for 
invasive electrophysiologic studies and implantation of ar- 
rhythmia control devices. Faculty should include specialists 
who are skilled in the medical and surgical aspects of pacing 
and electrophysiology. The faculty may be heterogeneous; 
however, at least one faculty member must be board certified 
by the ABIM in clinical cardiac electrophysiology (or its 
equivalent), and the same or another faculty member must be 
recognized as an expert in pacing for accrediting advanced 
levels of training in each respective area. 
Levels of Training 
Level 1. Within the cardiology core training program, level 
1 should be at least 2 months of clinical rotation designed for 
cardiology trainees to acquire knowledge and experience inthe 
diagnosis and management of bradyarrhythmias nd tachyar- 
rhythmias. The cardiology trainee should learn the indications 
for and limitations of electrophysiologic studies, the appropri- 
ate use of pharmacologic and nonpharmacologic therapeutic 
options and the proper and appropriate use of antiarrhythmic 
agents, including drug interactions and proarrhythmic poten- 
tial. The level 1 trainee should be exposed to noninvasive and 
invasive techniques related to the diagnosis and management 
of patients with cardiac arrhythmias that include ambulatory 
electrocardiographic (ECG) monitoring, event recorders, ex- 
ercise testing for arrhythmia ssessment, tilt table testing, 
signal-averaged electrocardiography, invasive electrophysi- 
ologic testing and implantation of cardiac arrhythmia control 
devices. These requirements are in addition to the basic ECG 
training as addressed in Task Force 2 and would require an 
additional minimum of 2 months. 
Electrocardiographic manifestations of arrhythmias should 
be taught on a regular basis during formal ECG conferences. 
Additional experience in heart rhythm disorders and clinical 
correlations can be obtained from didactic sessions and con- 
ferences; however, they must be supplemented byrotation on 
an arrhythmia consultation service, during which time the 
trainee should gain first-hand experience as a consultant in 
arrhythmia management. Arrhythmias associated with congen- 
ital heart disease, cardiac and noncardiac surgical patients and 
the pre- and post-cardiac transplantation patient are impor- 
tant components of the arrhythmia core training. The level 1 
cardiology trainee experience should also include learning the 
fundamentals of cardiac pacing; recognizing normal and abnor- 
mal pacemaker function; and knowing indications for temporary 
and permanent pacing, pacing modes and the general approach 
to programming and surveillance of pacemakers and implantable 
cardioverter-defibrillators. 
The cardiology trainee should also be formally instructed in 
and gain experience with 1) the insertion, management and 
follow-up of temporary pacemakers (6); 2) measuring pacing 
and sensing thresholds and recording electrograms for man- 
agement of patients with temporary pacemakers; and 3) indi- 
cations and techniques for elective and emergency cardiover- 
sions (7). Insertion of a minimum of 10 temporary pacemakers 
and performance of at least eight elective cardioversions i  
required. These experiences can be obtained throughout the 
24-month clinical training period. 
Level 2. All candidates for level 2 training must meet all 
training requirements under level 1. Level 2 training consists of 
a minimum of 6 months of training as a noninvasive cardiac 
arrhythmia specialist with advanced competency and profi- 
ciency in the diagnosis, treatment and longitudinal care of 
patients with complex arrhythmias. Level 2 trainees should 
meet all level 1 requirements and, in addition, should obtain 
advanced training in normal and abnormal cardiac electro- 
physiology and mechanisms of arrhythmias and proficiency in 
the performance and interpretation of noninvasive diagnostic 
procedures (ambulatory ECG monitoring, event recording, 
telephone ECG transmission, signal-averaged electrocardiog- 
raphy, tilt table testing, heart rate variability and other tests of the 
autonomic nervous ystem). Level 2 trainees hould also acquire 
knowledge of basic and clinical pharmacology of antiarrhythmic 
agents and proficiency in their use. Of special importance for the 
level 2 trainee is the acquisition of skills and experience for 
managing inpatients and outpatients with complex cardiac ar- 
rhythmias, including programming and follow-up management of 
all types of bradycardia pacing systems. The trainee is expected to 
function as the primary programming operator who interrogates, 
interprets, prescribes and reprograms in at least 100 patients. The 
trainee at this level must also acquire advanced expertise in 
temporary pacing, transesophageal atrial pacing, cardioversion, 
interpretation of invasive lectrophysiologic study data and com- 
plex arrhythmia ECG interpretation. Although the level 2 trainee 
must have significant exposure to invasive lectrophysiology, 
implantable cardioverter-defibrillators andthe surgical aspects of 
arrhythmia control device implantation, level 2 training will not 
qualify him or her to perform these invasive procedures. The level 
2 trainee has the option of obtaining additional training in the 
surgical aspects of pacemaker implantation or may choose the 
additional training required for invasive cardiac electrophysiol- 
ogy, or both, as described under level 3. 
Level 3. This level of training is designed for the individual 
who wishes to specialize in invasive diagnostic and therapeutic 
cardiac electrophysiology (clinical cardiac electrophysiology) 
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Table 1. Cardiac Arrhythmia nd Electrophysiology Curriculum 
Training Summary 
Optional Training 
Time in Device 
Level Curriculum/Skills Requirement Implantation 
1 Cardiac arrhythmia nd 2 mo (in addition No 
electrophysiology to Task Force 
core 2 training 
requirements) 
6 mo Advanced noninvasive 
arrhythmology 
3 Clinical invasive cardiac 1 yr 
electrophysiology 
(meets the ABIM 
CCEP Examination 
requirements) 
Yes: In addition to 6 mo 
of noninvasive 
emphasis, another 6
mo for a total of 12 
mo is required for 
pacemaker 
implantation training 
Yes: A total of 1 yr 
beyond the 3-yr 
cardiology training 
program is required. If 
surgical aspects of 
device implantation are 
desired, a total of 12 
mo within the 4 yr will 
need to be devoted to 
these disciplines 
ABIM = American Board of Internal Medicine; CCEP - Clinical Cardiac 
Electrophysiology. 
(8). Requirements of levels 1 and 2 must be fully met. Clinical 
cardiac electrophysiology training will include a minimum of 4 
years of training in clinical cardiology and electrophysiology. 
Two years of training must be in clinical cardiology and 2 years 
in electrophysiology, 1 year of which may be research related, 
or 3 years of training in clinical cardiology followed by a 
dedicated fourth year of training in clinical cardiac electro- 
physiology. The appropriate use, safe performance and judi- 
cious interpretation of these complex procedures requires 
highly specialized training and competence and cannot be 
completed in a 3-year training program. Further, an advanced 
knowledge base in basic clinical cardiac electrophysiology and 
pharmacology must provide a sound foundation for the acqui- 
sition of technical abilities and cognitive skills in management 
of patients with complex arrhythmias. 
To complete level 3, in addition to level 1 and 2 require- 
ments, trainees hould perform at least 100 electrophysiologic 
procedures as the primary operator or as an assistant involved 
with the acquisition and analysis of the data. Electrophysi- 
ologic procedures should cover the total spectrum of arrhyth- 
mias, both supraventricular nd ventricular tachyarrhythmias, 
as well as bradyarrhythmias. At least 50 of these procedures 
should be in patients with supraventricular tachyarrhythmias. 
Expertise in catheter placement, programmed electrical stim- 
ulation, endocardial mapping, catheter ablation and interpre- 
tation of data must be assured by the electrophysiology pro- 
gram director. The endocardial mapping experience should 
include at least 15 cases of left heart mapping using the retrograde 
aortic approach. If expertise in transseptal catheterization is
required, training should be by an individual at the training 
institution with expertise in the technique. Experience with at 
least 10 transseptal catheterization procedures i suggested as 
minimal required training. Participation in a minimum of 50 
catheter ablations, including ablation and modification of the 
atrioventricular (AV) node, AV accessory pathways, atrial flutter 
and atrial and ventricular tachycardia s required. The trainee in 
electrophysiology requires implantable cardioverter-defibrillator 
experience that includes assisting with the primary device implan- 
tation with electrophysiologic testing at the time of implantation 
and with follow-up assessment. This experience will include at 
least 50 device evaluations (combined implantation and follow- 
up). Although the level 3 trainee must have significant exposure 
to the management and follow-up of implantable cardioverter- 
defibrillator pacemaker implantation, he or she will not necessar- 
ily be trained in the surgical aspects of these procedures (Table 1). 
Optional Training in Device Implantation 
(Applicable to Level 2 or Level 3) 
Level 2 and 3 trainees may choose to obtain additional 
training in the surgical aspects of device implantation. This device 
implantation training may be obtained concurrently or sequen- 
tially with level 2 or level 3, respectively. Training for the surgical 
implantation of permanent bradycardia pacing systems can be 
obtained in both levels 2 and 3, whereas training in the surgical 
implantation of implantable cardioverter-defibrillators can be 
obtained in level 3 only. Training in the surgical aspects of device 
implantation should not take place without he supporting train- 
ing of level 2 or level 3 training, or both. 
For those cardiology trainees who elect to obtain profi- 
ciency in the surgical aspects of transvenous bradycardia device 
implantation (pacemakers), previous or concurrent level 2 
training is required. The pacemaker implantation training 
must include developing expertise in permanent atrial and 
ventricular lead placement, hreshold testing and program- 
ming of devices, principles of surgical asepsis, surgical tech- 
niques of implantation and management of implant-related 
complications. Individuals receiving qualifying training in 
pacemaker implantation must participate as the primary oper- 
ator (but under direct supervision) in at least 50 primary 
implantations of transvenous pacemakers and 20 pacemaker 
system revisions or replacements. At least half of the implan- 
tations should involve dual-chamber pacemakers. The trainee 
must also participate inthe follow-up of at least 100 pacemaker 
patient visits and acquire proficiency in advanced pacemaker 
electrocardiography, interrogation and programming of com- 
plex pacemakers. Level 2 training (6 months) with the option 
of training in pacemaker implantation (6 months) requires a 
total of 1 year of advanced training beyond the cardiology core 
level 1. This may be obtained within a 3-year cardiology 
program if 1 of the 3 years is dedicated to acquiring pacemaker 
implantation skills plus related management and follow-up 
skills. This training does not meet he ABIM requirements for 
admission to the CCEP Examination. 
The trainee pursuing a career in cardiac electrophysiology 
as addressed under level 3 also has the option of obtaining 
expertise in the surgical aspects of pacemaker or transvenous 
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implantable cardioverter-defibrillator implantation, or both. 
The same amount of surgical experience with bradycardia 
pacemaker implantation is required and may be supplemented 
with surgical training for implantable cardioverter-defibrillator 
implantation. If the level 3 trainee chooses this option, he or 
she must participate as the primary implanter (under direct 
supervision) in at least 20 implantable cardioverter- 
defibrillator system implantations as well as the management 
and follow-up skills addressed under level 3. The trainee must 
also participate in the surgical replacement or revision of at 
least 10 implantable cardioverter-defibrillator systems and 
follow-up of at least 50 implantable cardioverter-defibrillator 
patient visits. Level 3 training with the option of pacemaker or 
implantable cardioverter-defibrillator implantation, or both, 
requires a minimum of 1 year of dedicated clinical cardiac 
electrophysiology and device implantation training beyond the 
3-year cardiology program. 
Evaluation, Competency and Privileges 
The program director should maintain adequate records of 
each individual's training experiences and performances of 
various procedures for appropriate documentation for levels 1, 
2 and 3. The trainees hould also maintain records of partici- 
pation in the form of a logbook containing clinical information, 
procedure performed and outcome of procedures, including 
any complications encountered. 
Competency examinations in electrocardiography and 
other self-assessment programs are available through the 
ACC. Training directors and trainees are encouraged to utilize 
the resources. The ACGME has recently published the essen- 
tial components of a specialized program for training in clinical 
cardiac electrophysiology. The ABIM provides a special exam- 
ination for additional certification in clinical cardiac electro- 
physiology. Information concerning the training requirements 
for admission to the examination can be obtained from the 
ABIM; NASPE also has a written examination of special 
competency in device therapy, but it does not provide certifi- 
cation. 
Subsequent privileges to perform invasive procedures 
should be primarily granted on the basis of the technical 
expertise acquired in the training program, the documented 
training and the recommendations of the directors of electro- 
physiology/pacing programs. 
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Task Force 7: Training in Cardiovascular Research 
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RODMAN D. STARKE,  MD,  FACC 
All cardiology training should be carried out in institutions 
in which the opportunity to participate in research is available. 
The training site should be one that will provide an atmosphere 
of intellectual inquiry and support of the investigational 
process. 
It is important hat every cardiovascular t ainee participate 
directly in research. Cardiology is a dynamic linical field where 
rapid transfer of knowledge from basic and clinical research to 
clinical care will continue to occur. This pattern will only 
accelerate in the future. Cardiovascular research is defined in 
